How to prevent contamination with Candida albicans during the fabrication of transplantable oral mucosal epithelial cell sheets.

"Disclosure statement Teruo Okano is a founder and director of the board of CellSeed Inc., licensing technologies and patents from Tokyo Women's Medical University. Teruo Okano and Masayuki Yamato are shareholders of CellSeed Inc. Tokyo Women's Medical University is receiving research funding from CellSeed Inc."

"This work was supported by the Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology ‘Cell Sheet Tissue Engineering Center (CSTEC)’ and by the Global Center of Excellence Program's Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM) established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan."